Identification and uses of brain activity networks
AssigneeThe Feinstein Institute for Medical Research
InventorDavid Eidelberg
Life of this patent
Estimating the term…
Abstract
Methods for identifying networks correlating with placebo effects, progression of neurological disease symptoms, progression of pre-phenoconversion states of neurological diseases, and efficacious/non-efficacious candidate treatments for neurological diseases are provided.
Claims27
A method for identifying a pattern of brain activity associated with a placebo effect response to a placebo treatment for a disease or disorder comprising:
- determining, by positron emission tomography (PET) or magnetic resonance imaging (MRI) in a subject receiving, or who has received, the placebo treatment for the disease or disorder, functional activity at each of a plurality of coordinates of the subject's brain during at least two different time points and identifying, through spatial co-variance analysis of the functional activity, which coordinates show a consistent trend over the at least two different time points in functional activity correlating with a placebo effect response to the placebo treatment,
- so as to thereby determine a pattern of brain activity associated with a placebo effect response to a placebo treatment for a disease or disorder.
3-5. (canceled)
(canceled)
12-16. (canceled)
(canceled)
A method for determining efficacy of a candidate treatment, administered to a subject having a brain disorder, on a rate of progression of the brain disorder comprising:
- a) determining, by positron emission tomography (PET) or magnetic resonance imaging (MRI) during administration of or after administration of the candidate treatment to the subject, functional activity at each of a plurality of predetermined coordinates of the subject's brain so as to determine a first pattern of activity, which coordinates have previously been identified through spatial co-variance analysis of functional activity as determined by PET or MRI in the brain of the subject or in the brain(s) of one or more other subjects suffering from the brain disorder during at least two different time points while the subject was, or subjects were, exhibiting the symptom or brain disorder as showing a consistent trend in functional activity which correlates with worsening of the brain disorder;
- and
- b) comparing the first pattern of activity determined in step a) with a previously determined baseline pattern of activity,
- wherein an expression of the first pattern of activity lower than the previously determined baseline pattern of activity indicates that the candidate treatment is efficacious in reducing the rate of progression of the brain disorder, and wherein an expression of the first pattern of activity higher than the previously determined baseline pattern of activity indicates that the candidate treatment is not efficacious in reducing the rate of progression of the brain disorder.
(canceled)
A method for identifying a pattern of brain activity specifically associated with a symptom of a brain disorder comprising:
- determining, by positron emission tomography (PET) or functional magnetic resonance imaging (MRI) in a subject exhibiting the symptom, functional activity at each of a plurality of coordinates of the subject's brain during at least two different time points and identifying, through spatial co-variance analysis of the functional activity, which coordinates show a consistent trend over the at least two different time points in functional activity correlating with the symptom,
- so as to determine a baseline pattern of activity specifically associated with the symptom of the brain disorder.
(canceled)
A method for identifying a pattern of brain activity specifically associated with efficacious treatment of a symptom of a brain disorder comprising:
- determining, by positron emission tomography (PET) or magnetic resonance imaging (MRI) in a subject exhibiting the symptom and being treated with a treatment efficacious for that symptom, functional activity at each of a plurality of coordinates of the subject's brain during at least two different time points and identifying, through spatial co-variance analysis of the functional activity, which coordinates show a consistent trend over the at least two different time points in functional activity correlating with efficacious treatment of the symptom, so as to thereby determine a baseline pattern of activity specifically associated with efficacious treatment of the symptom of the brain disorder.
A method for identifying a pattern of brain activity specifically associated with a pre-phenoconversion rate change of a neurological disease comprising:
- determining, by positron emission tomography (PET) or magnetic resonance imaging (MRI) in a subject in a pre-phenoconversion state, functional activity at each of a plurality of coordinates of the subject's brain during at least two different time points and identifying, through spatial co-variance analysis of the functional activity, which coordinates show a consistent trend in functional activity over the at least two different time points correlating with the pre-phenoconversion rate,
- so as to thereby determine a pattern of brain activity specifically associated with the pre-phenoconversion rate change of the neurological disease.
26-58. (canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.